Co Etidronate · DIN 02248686 · 200 mg · tablet
Limited Use, Reason for Use code 236, 237 required; Health Canada lists this DIN as Cancelled post market since 2022-05-30 — choose a marketed DIN from the same-category list.Discontinued May 30, 2022 · checked November 17, 2026
StatusLimited Use, Reason for Use code 236, 237 required; Health Canada lists this DIN as Cancelled post market since 2022-05-30 — choose a marketed DIN from the same-category list.
Write on scriptone applicable Reason for Use code, 236 or 237 (criteria below); Health Canada lists this DIN as Cancelled post market since 2022-05-30 — choose a marketed DIN from the same-category list.
Patient paysIf the Reason for Use code is written and the criteria are met, ODB 65 and over pays:
• ODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
• Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
If the criteria are not met, ODB does not pay this product under Limited Use. [Limited Use benefit, Formulary flag]
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Ontario Limited Use criteria, code 236, 237
Reason for Use code 236
For the treatment of Paget's disease;
Coverage limit:
LU Authorization Period: Indefinite
Reason for Use code 237
For the management of hypercalcemia of malignancy.
Coverage limit:
LU Authorization Period: Indefinite
1 brand, same coverage
Co Etidronate · DIN 02248686
Manufacturer: Cobalt Pharmaceuticals Company; listing date 2005-01-25
Health Canada: Cancelled post market since 2022-05-30 · brand ACT ETIDRONATE · ATC M05BA01 ETIDRONIC ACID · form Tablet · route Oral · ingredients ETIDRONATE DISODIUM 200 MG · company Teva canada limited · schedule Prescription
Co Etidronate: Formulary list price $0.36 per unit (the source does not state the unit; exact figure $0.3569). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02248686)
Source record
DIN 02248686: Co Etidronate
Raw flags: chronicUseMed=Y, sec12=Y, sec3=Y
Item: 920000045; group id 912; item number 2186; lccId 00126; manufacturer id COB
Source form: Tab; strength: 200mg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below; chronic-use medication (100-day supply rule, dispensing-fee limit)
Source prices (unrounded): $0.3569; ministry $0.3569
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02248686
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=73050
Interchangeable products
Didronel · DIN 01997629 · not recorded
Shortage status: not checked (no credentials)
Health Canada lists this DIN as Cancelled post market since May 30, 2022 — choose a marketed DIN from the same-category list.